We expect the COVID-19 situation being significantly improved by April 2022, with live conferences being authorized again in Europe and most travel restrictions being lifted. The EUROGIN 2022 organizers will take all necessary measures in accordance with national government and local authority guidance to make sure participants can attend safely.
Welcome
Dear Colleagues – Welcome to Düsseldorf!
After many months of social distancing and virtual meetings we will have the opportunity to meet in person, share ideas, have an open and vigorous scientific dialogue, and meet friends and colleagues from around the world at the upcoming EUROGIN meeting, taking place in Dusseldorf on April 10-12, 2022. The ambitious goal of Eliminating Cervical Cancer Globally remains a major focus, as does expanding these efforts to all cancers caused by HPV among women and men. As a community we will need to recover from the losses in cervical cancer screening and treatment and HPV vaccination rates that we witnessed during the COVID-19 pandemic, and quickly develop and implement an aggressive plan to forge forward to achieve this goal. Research is needed more than ever to develop cost-effective methods to increase screening, optimize screening protocols, and develop simple treatment strategies that are practical for all communities to implement, regardless of economic status.
As co-presidents, we look forward to EUROGIN 2022 as the meeting where we propel all of our efforts and recharge our collective urge to see a world in the not-too-distant future where cervical and other HPV-related cancers no longer exist.
A. Giuliano (USA) & P. Hillemanns (Germany), Congress Presidents
EUROGIN 2022 will be in-person!
After a challenging period due to the COVID-19 pandemic, the EUROGIN 2022 Organizing Committee is thrilled to welcome the HPV community to meet again in person in Düsseldorf on April 10-12, 2022.
Back to the face-to-face format, the event will offer the usual high level of scientific content brought to you by the most reputable world-class experts in the field, throughout 4 days, comprising a large array of scientific and clinical sessions, and specialized workshops.
Why you should attend
- Under the scientific supervision of Joseph Monsonego, EUROGIN features a highly interactive, stimulating and cutting-edge program on HPV infections and related diseases.
- The meeting is tailored to entice the exchange of ideas and latest scientific findings and further their application in clinical practice.
- EUROGIN 2022 is the first large international in-person conference in the field of HPV-related diseases. This highly awaited event is expected to be attended by over 1,500 delegates from all over the world, including gynecologists, biologists, epidemiologists, immunologists, pathologists, head & neck specialists, public health representatives and other professionals.
- Hundreds of abstract submissions for free communications and posters will add to the latest and most relevant scientific developments in the field.
Preliminary Program of main congress
Check out our preliminary program
For sessions without agenda details: this information will be added in due time
Full Day Workshop (APril 10, 2022)
Revisiting high-grade intraepithelial neoplasia – molecular biology, risk management and prevention
Coordinator: J. Monsonego (France)
Specialized Workshops
- The Feasibility of Personalized Screening in Organized Programs
- April 10, 2022
Coordinators: S. Van Dijk (Netherlands), P. Giorgi Rossi (Italy), M. Elfström (Sweden) - HPV infection and anal diseases
- April 10, 2022
Coordinator: J. Palefsky (USA) - Vulvar Diseases - April 12, 2022
Coordinators: J. Bornstein (Israel), M. Preti (Italy), P. Vieira-Baptista (Portugal), J. Paavonen (Finland), G. Donders (Belgium) - Colposcopy course (Separate registration required - Limited capacity) - April 10, 2022
Coordinators: A. Singer (UK), J. Bornstein (Israel)
HPV and Head & Neck Forum
Coordinators: P. Klussmann (Germany), K. Lang Kuhs (USA), E. Rettig (USA)
The EUROGIN HPV and Head & Neck Cancer Forum highlights recent advances and areas of active research in the field of HPV-related head and neck cancers.
This year’s Forum features the emerging role of biomarkers in screening and management of HPV-related oropharyngeal cancer, updates epidemiological data, emphasizes survivorship and surveillance, highlights deintensification trials and other therapeutic innovations, and a dedicated session focusing on molecular & immunologic considerations.
Sponsorship
For sponsorship and exhibition enquiries, please contact Peter Mattonet: [email protected]
Ethical Med Tech
The EUROGIN congress has been vetted as COMPLIANT by the Ethical Med Tech conference vetting system on all assessment criteria:
- Scientific Programme
- Geographic Location
- Conference Venue
- Hospitality
- Registration Packages
- Communication
EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.
EUROVIR, owning the trademark EUROGIN, is a Trusted Partner of Ethical MedTech.